The pathogenesis of osteoporosis

Bone and Mineral

Volumn 9, Issue 3, 1990, Pages 215-227

  Gallagher, J C ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; SEX DIFFERENCE; VITAMIN D METABOLISM;

ABSORPTION; AGED; AGING; BONE AND BONES; BONE DEVELOPMENT; BONE RESORPTION; CALCITRIOL; CALCIUM; FEMALE; HUMAN; MALE; MIDDLE AGE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONES;

EID: 0025352580     PISSN: 01696009     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-6009(90)90039-I     Document Type: Article

References (81)

1. Limb fractures in a defined population. II. Orthopedic treatment and utilization of health care
2. Epidemiology of osteoporosis and osteoporotic fractures
3. Secular trends in the incidence of hip fractures
4. The effect of calcium regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones
5. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption
6. Conditioned medium from osteoblast-like cells mediate parathyroid hormone induced bone resorption
7. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption
8. Synergism between parathyroid hormone and interleukin 1 in stimulating bone resorption in organ culture
9. Human skeletal growth factor: characterization of the mitogenic effect on bone
10. Identification and quantification of four distinct growth factors stored in human bone matrix
11. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption
12. Expression of the osteoblastic phenotype
13. 3 parathyroid hormone and glucocorticoids
14. 3 increases serum levels of the vitamin K-dependent bone protein
15. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis
16. Spine and femur density using dual-photon absorptiometry in US white women
17. Bone mineral density of the spine and proximal femur in normal and osteoporotic subjects in Japan
18. The effect of age and menopause on bone mineral density of the proximal femur
19. Influence of the menopause and aging on spinal density in French women
20. Models of spinal trabecular bone loss as determined by quantitative computed tomography
21. Early menopausal changes in bone mass and sex steroids
22. Spinal mineral loss in oophorectomized women
23. Total bone calcium in normal women: effect of age and menopausal status
24. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
25. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis
26. Bone mineral content of amenorrheic and eumenorrheic athletes
27. Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women
28. Postmenopausal osteoporosis
29. Evidence for two distinct syndromes of involutional osteoporosis
30. A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D
31. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes
32. Physiological senile involution and pathological rarefaction of bone: quantitative and comparative histological data
33. Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone
34. Histological heterogeneity of apparently idiopathic osteoporosis
35. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium
36. Intestinal absorption of Ca in senile osteoporosis
37. The crush fracture syndrome in postmenopausal women
38. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women
39. Osteoporosis and osteomalacia
40. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis
41. Risk factors for postmenopausal osteoporosis
42. Studies in the metabolism of calcified 16. Determination of the concentration of 25-hydroxyvitamin, 24,25-dihydroxyvitamin and 1,25-dihydroxyvitamin D in a single 2 milliliter plasma sample
43. Assessment of 25-hydroxyvitamin D 1-alpha-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract
44. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis
45. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis
46. Deficiency of calcitonin in age related osteoporosis
47. Calcitonin secretion in post-menopausal osteoporosis
48. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis
49. Bone density of the radius, spine and proximal femur in osteoporosis
50. Effect of age on calcium absorption
51. Histomorphometric profile and vitamin D status in patients with femoral neck fracture
52. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel
53. Increases in immunoreactive parathyroid hormone with age
54. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans
55. Increase in serum bone-carboxyglutamic acid protein with aging in women: implications for the mechanism of age-related bone loss
56. Effect of age on serum immunoreactive parathyroid hormone and its biological effects
57. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis
58. Risk factors for spinal osteoporosis in men
59. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton
60. Spiral osteoporosis in men
61. Examination of prevalence rates of possible risk factors in a population with a fracture of the proximal femur
62. In women dietary calcium intake and rates of bone loss from midradius and lumbar spine are not related
63. Prevention of spinal osteoporosis in oophorectomised women
64. Intestinal absorption of calcium-47 after treatment with oral estrogen and gestagen in senile osteoporosis
65. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women
66. Anabolic effect of human parathyroid fragment on trabecular bone in involutional osteoporosis: a multicentre trial
67. Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients
68. Deficient production of 1,25-dihydroxvitamin D in elderly osteoporotic patients
69. Drug therapy: calcitonin, biphosphonates anabolic steroids, and hPTH(1-34)
70. Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment
71. 3: shortand long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis
72. Calcitriol in the treatment of postmenopausal osteoporosis
73. 3 1-alpha-hydroxycholecalciferol and 1,24-dihydroxycholecalciferol and 1,24-dihydroxycholecalciferol
74. Calcitriol treatment is not effective in postmenopausal osteoporosis
75. 3
76. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency
77. 3 in preventing spinal fractures of patients with osteoporosis
78. Excessive l-thyroxine therapy and the rate of lumbar spine bone mineral loss